Current Clinical Trials for Stem Cell Transplant

GCC 0562-B - Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors

GCC 0851 - Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response. BMT/CTN 0701

GCC 1034 - A Phase 1b Study of GDC-0449 following autologous transplantation in patients with high risk first remission or relapsed multiple myeloma

GCC 1038 - A Phase III, Double-Blind, Randomized, Placebo-Controlled,Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy,Hematopoietic Cell Transplants (HCTs)

GCC 1056 - Phase I/IIa dual-cohort, two-site, clinical trial evaluating the safety and activity of redirected autologous T cells expressing a high-affinity TCR specific for MAGE-A3/6 or NY-ESO-1 administered post-ASCT in patients with advanced myeloma

GCC 1065 - High Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients

GCC 1135 - Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals

GCC 1150 - A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications.



Email this Page                                                                     Print this Page

Home Site Map Disclaimer University of Maryland Greenebaum Cancer Center UM School of Medicine UM Medical System UM Medical Center Text: If you would like to make an appointment or talk to someone about our services please call 1-800-888-8823. Physicians can call our dedicated consultation referral service at 1-800-373-4111.